跳至主要内容
临床试验/NCT03742466
NCT03742466已完成不适用

Local Injection of Ozone Versus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma Patients. A Single-blind Randomized Clinical Trial

Assiut University1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2018年11月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
50
试验地点
1
主要终点
to assess pain alleviation through the visual analog scale (VAS)

研究概览

简要总结

Carpal tunnel syndrome is a common peripheral entrapment neuropathy, this study aims to investigate if, and to what extent local ozone therapy could offer symptom improvement in scleroderma patients with Carpal tunnel syndrome

详细描述

Carpal tunnel syndrome (CTS) is the most common compression syndrome the upper extremities. Its problem has a high prevalence ranged estimated prevalence of 3.8% in the general population, 3 and 7.8% in the working population. It occurs at any age, especially in individuals in their 40s to 60s, and the male: female ratio is reported to be 3:7. A lot of treatment modalities have been tried to improve the condition, starting from local anesthetic injection, steroid, and up to surgical decompression of the nerves.

Scleroderma patients are a special group which usually sufferers from such problem

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • adult patients with scleroderma
  • complaining of carpal tunnel syndrome of 3-month duration or more
  • diagnosed axonal neuropathy using electrodiagnosis, nerve conduction study

排除标准

  • patient refusal
  • infection at the site of intervention
  • previous injection in the recent 3 months
  • Coagulopathy

研究组 & 干预措施

Ozone

Active Comparator

After prepping and draping the area, intracarpal injection of ozone/oxygen mixture (20 ml, 25μg/ml) will be performed under sonographic guidance

干预措施: Ozone (Drug)

methylprednisolone acetate

Active Comparator

After prepping and draping the area, intracarpal injection of methylprednisolone acetate 40mg, and 40 mg lidocaine (20 ml, volume) will be performed under sonographic guidance

干预措施: methylprednisolone acetate (Drug)

结局指标

主要结局

to assess pain alleviation through the visual analog scale (VAS)

时间窗: 6 months

visual analog scale of pain value of (0 cm) no pain , and value of (10 cm) worst pain

次要结局

  • Changes in median nerve conduction parameters(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Emad Zarief , MD

Associate professor of Anesthesia, ICU, and pain

Assiut University

研究点 (1)

Loading locations...

相似试验